Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crh Public (CRH) Cash & Equivalents (2016 - 2025)

Crh Public's Cash & Equivalents history spans 10 years, with the latest figure at $4.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 10.11% year-over-year to $4.1 billion; the TTM value through Dec 2025 reached $4.1 billion, up 10.11%, while the annual FY2025 figure was $4.1 billion, 10.11% up from the prior year.
  • Cash & Equivalents reached $4.1 billion in Q4 2025 per CRH's latest filing, down from $4.2 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $6.3 billion in Q4 2023 to a low of $2.9 billion in Q2 2025.
  • Average Cash & Equivalents over 5 years is $4.3 billion, with a median of $4.1 billion recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: tumbled 47.96% in 2024, then skyrocketed 40.97% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $5.8 billion in 2021, then rose by 2.65% to $5.9 billion in 2022, then increased by 6.82% to $6.3 billion in 2023, then crashed by 41.33% to $3.7 billion in 2024, then rose by 10.11% to $4.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CRH's Cash & Equivalents are $4.1 billion (Q4 2025), $4.2 billion (Q3 2025), and $2.9 billion (Q2 2025).